Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Top Ten most popular articles on Pharmafile.com this week

January 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday, and there have been some big revelations for the pharma industry this week. Brexit, the ever-present hot topic …
News

Pharmaceutical R&D tax credit regulatory legislation: The need for clarity

January 20, 2017 Medical Communications, Research and Development, Sales and Marketing R&D, pharmafile

Since their introduction in the UK in 2000, R&D tax credits have provided a significant boost to pharmaceutical and biotech …
News

Sanofi diabetes drug Sulinqua green-lighted in Europe

January 19, 2017 Research and Development, Sales and Marketing Sanofi, Sulinqua

Sanofi’s diabetes drug Suliqua has been granted marketing authorisation by the European Commission, giving the go ahead for the launch …
News

Boehringer steps into Humira race with US and EU biosimilar filings

January 19, 2017 Sales and Marketing Boehringer Ingelheim, Humira, biosimilar

Boehringer Ingelheim has just stepped into the ring to battle it out for a slice of Humira’s revenue with accepted …
News

GSK snatches AZ Europe VP to replace exiting global head of pharma

January 19, 2017 Business Services, Medical Communications, Sales and Marketing Abbas Hussain, Luke Miels

GlaxoSmithKline has announced that its global head of pharmaceuticals Abbas Hussain (pictured) is leaving the company; the vacated role will …
News

Allergan fined £15m over failure to disclose merger discussions

January 19, 2017 Sales and Marketing Allergan, SEC

Allergan has been fined $15 million by the Security and Exchange Commission (SEC) after committing disclosure violations during merger talks …
News

Lilly brings migraine drug home with $960m acquisition

January 19, 2017 Sales and Marketing CoLucid Pharmaceuticals, Eli Lilly

Eli Lilly has announced it is to shell out $960 million to snatch up CoLucid Pharmaceuticals and specifically its migraine …
News

Biogen shells out $1.25bn to protect best-selling MS drug

January 18, 2017 Research and Development, Sales and Marketing Biogen, Forward Pharma, multiple sclerosis, tecfidera

Biogen has announced it is to pay $1.25 billion to Copenhagen-based biotech Forward Pharma in the latest development in a …
News

PM May announces Brexit plan, BioIndustry Association CEO reacts

January 18, 2017 Research and Development, Sales and Marketing Theresa May, brexit

After months of uncertainty following the UK’s vote to leave the EU, Theresa May has finally announced the first inklings …
News

SMC rejects Janssen’s multiple myeloma treatment Darzalex

January 17, 2017 Manufacturing and Production, Sales and Marketing Janssen, SMC, darzalex

The Scottish Medicines Consortium (SMC) has decided not to recommend Janssen’s Darzalex (daratumumab) for routine use by NHS Scotland as …
News

Merck forges data analytics partnership with Palantir

January 17, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Merck, Palantir

Merck has teamed up with software and data-mining firm Palantir with the intention to utilise its data analytics services to …
News

AZ to rework ongoing immuno-oncology trials to “enhance options”

January 17, 2017 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, non-small cell lung cancer

Due to the “strong efficacy” shown by its durvalumab as a treatment for non-small cell lung cancer (NSCLC), AstraZeneca has …
News

Benzodiazepines increase stroke risk in Alzheimer’s patients, study finds

January 16, 2017 Research and Development, Sales and Marketing Alzheimer's, Alzheimers, benzodiazepines

Benzodiazepines and similar drugs could increase the risk of strokes in Alzheimer’s patients by as much as 20% according to …
News

J&J to reveal drug price increases next month

January 16, 2017 Sales and Marketing Johnson & Johnson

Next month, Johnson & Johnson will reveal the average price increases of its prescription drugs in a move to increase …
News

Novo strikes up personalised diabetes treatment deal with Glooko

January 16, 2017 Sales and Marketing Glooko, Novo Nordisk, ibm

Novo Nordisk has entered into a partnership with Californian firm Glooko to develop a number of offerings to aid with …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026